Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Cephalexin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cephalexin and what is the scope of cephalexin freedom to operate?

Cephalexin
is the generic ingredient in five branded drugs marketed by Ranbaxy Labs Ltd, Teva, Pragma Pharms Llc, Sun Pharm Inds Ltd, Purepac Pharm, Belcher Pharms, Hikma, Facta Farma, Orchid Hlthcare, Barr, Lupin, Alkem Labs Ltd, Yung Shin Pharm, Lilly, Hikma Pharms, Aurobindo Pharma Ltd, Apothecon, Vitarine, Ivax Sub Teva Pharms, Stevens J, Yoshitomi, and Sun Pharm Inds (in), and is included in fifty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for cephalexin. Sixty-one suppliers are listed for this compound.

Summary for Generic Name: cephalexin

Tradenames:5
Patents:1
Applicants:22
NDAs:55
Drug Master File Entries: see list29
Suppliers / Packagers: see list61
Bulk Api Vendors: see list33
Clinical Trials: see list14
Patent Applications: see list5,893
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cephalexin at DailyMed

Pharmacology for Ingredient: cephalexin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vitarine
CEPHALEXIN
cephalexin
FOR SUSPENSION;ORAL062781-001Dec 22, 1987DISCNNoNo► Subscribe► Subscribe
Pragma Pharms Llc
KEFLEX
cephalexin
FOR SUSPENSION;ORAL050406-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Purepac Pharm
CEPHALEXIN
cephalexin
CAPSULE;ORAL062809-001Apr 22, 1987DISCNNoNo► Subscribe► Subscribe
Hikma Pharms
CEPHALEXIN
cephalexin
FOR SUSPENSION;ORAL065444-002Aug 28, 2009DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
CEPHALEXIN
cephalexin
FOR SUSPENSION;ORAL065081-001Jul 27, 2001DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot